Available IPD datapackage for study 'A Multicenter, Open-Label, Functionality, Reliability and Performance Study of a Single-Use Auto-Injector With Home-administered Subcutaneous Benralizumab in Adult Patients With Severe Asthma (GRECO)'

The purpose of the study is to assess functionality, performance, and reliability of an single-use auto-injector (AI) with benralizumab administered subcutaneously (SC) in an at-home setting reported by the patient or caregiver, and to confirm the safety and clinical benefit of benralizumab administration in asthma patients with severe asthma

本研究旨在评估一款用于皮下注射（subcutaneously, SC）贝那利珠单抗（benralizumab）的一次性自动注射器（single-use auto-injector, AI）在居家使用场景下的功能、性能与可靠性，相关评估数据由患者或护理人员报告，并确认贝那利珠单抗给药方案在重症哮喘患者中的安全性与临床获益。